wire

Thousands of women who undergo radiotherapy for low-risk breast cancer could be spared some of the side effects of treatment after a study confirmed that more targeted treatments are just as effective at controlling the disease in the long term.

Removing incorrect penicillin allergy labels on GP records could combat antibiotic resistance and save lives, an NIHR-funded clinical trial led by the University of Leeds has found.

Professor Joanna Moncrieff (UCL Psychiatry) argues in The Conversation that a new review of antidepressant withdrawal effects risks underestimating the potential harms to long-term antidepressant users by focusing on short-term, studies.

A new study has opened in Manchester which could improve screening and early detection of lung cancer for high-risk Hodgkin lymphoma survivors, following a £1.3 million funding award.

The largest review of 'gold standard' antidepressant withdrawal studies to date has identified the type and incidence of symptoms experienced. The largest review of 'gold standard' antidepressant withdrawal studies to date has identified the type and incidence of symptoms experienced by people discontinuing antidepressants, finding most people do not experience severe withdrawal.

The largest review of 'gold standard' antidepressant withdrawal studies to date has identified the type and incidence of symptoms experienced by people discontinuing antidepressants, in a study involving UCL authors, finding that most people do not experience severe withdrawal.

The Early Detection of Liver Disease research project (ID LIVER) takes a targeted and streamlined approach to identifying, assessing and managing patients at increased risk of liver disease in underserved communities.

A creative play programme has significantly improved new parents' and carers' mental health, according to research by the Universities of Leeds and Huddersfield.

Cancer is costly for patients and the NHS - but it also has a significant impact on the UK economy, according to research led by the University of Leeds. The UK could save billions of pounds per year by focusing on cancer prevention, as well as finding and treating cancer earlier, according to the Cost of Cancer report , commissioned by Cancer Research UK.

A teenager who has lost family members including her mother because of a rare genetic hereditary illness has become the first patient in the UK and Europe to have a new treatment developed by Cambridge researchers and approved for use on the NHS.

Radioactive iodine treatment after thyroid cancer surgery usually means side effects like nausea and time in hospital isolated from loved ones. But new clinical trial results from researchers at UCL mean patients worldwide could now safely be spared this treatment. Globally, around 820,000 people are diagnosed with thyroid cancer each year.

University of Manchester scientists studying invasive aspergillosis are both the world's most cited and the most prolific on the topic, according to an analysis published by Guangxi university in the journal Medicine.

A major new study launching in Scotland aims to show how a simple genetic test could help doctors personalise treatments - boosting medication response and reducing harmful side effects.

A set of genes that could be used to help doctors predict which children will respond well to treatment for juvenile idiopathic arthritis (JIA) have been identified by researchers at UCL and Great Ormond Street Hospital for Children (GOSH), who are part of the CLUSTER Consortium. JIA is a childhood immune disease where the immune system attacks the body, in particular the lining of the joints.

Personalised drug treatments have outperformed chemotherapy for leukaemia patients in a trial led by Leeds researchers.

A study led by University of Manchester epidemiologists has revealed which opioid painkillers are most likely to be associated with constipation in patients with non-cancer pain.

Patients who received a one-off gene therapy to treat haemophilia are still doing well up to 13 years later, proving that the therapy is safe and long-lasting, finds a new study from researchers at UCL, the Royal Free Hospital and St Jude Children's Research Hospital, Tennessee. The study, published in New England Journal of Medicine , is the longest reported follow-up for any gene therapy for haemophilia B, a rare genetic disorder caused by insufficient levels of a protein in the blood, called factor IX (nine), that promotes clotting after injury.

A daily pill can prolong the lives of people with a "stiff heart" condition called cardiac amyloidosis who have also had surgery to replace a narrowed heart valve, according to a new study led by researchers at UCL and MedUni Vienna.

A daily pill can prolong the lives of people with a "stiff heart" condition called cardiac amyloidosis who have also had surgery to replace a narrowed heart valve, according to a new study led by researchers at UCL and MedUni Vienna. Aortic valve narrowing (aortic stenosis), the narrowing of the valve between the heart's left pumping chamber and the main artery, is often accompanied by cardiac amyloidosis, where misfolded proteins are deposited in the heart muscle.

A new artificial intelligence (AI) test can identify which men with prostate cancer will benefit most from the life-extending drug abiraterone, in clinical trial results presented by scientists from UCL and the Institute of Cancer Research.

A clinical trial led by researchers from UCL and UCLH, which is soon to get underway, aims to transform the lives of lupus patients who don't respond to current treatments.

A kinder treatment for anal cancer involving a lower dose and shorter course of radiotherapy is more effective than traditional treatment, a clinical trial led by Leeds researchers has found.

An innovative blood cancer treatment regime could extend remission by seven months on average, according to a clinical trial led by the University of Leeds.

A new treatment approach significantly improves survival rates for patients with aggressive, inherited breast cancers, according to Cambridge researchers. It is rare to have a 100% survival rate in a study like this and for these aggressive types of cancer Jean Abraham In a trial where cancers were treated with chemotherapy followed by a targeted cancer drug before surgery, 100% of patients survived the critical three-year period post-surgery.

People living in more deprived areas with worse health outcomes were 65% more likely to lose their local pharmacy than those in wealthier areas, according to research published today.

Women diagnosed with breast cancer who carry particular BRCA1 and BRCA2 genetic variants are offered surgery to remove the ovaries and fallopian tubes as this dramatically reduces their risk of ovarian cancer. Now, Cambridge researchers have shown that this procedure - known as bilateral salpingo-oophorectomy (BSO) - is associated with a substantial reduction in the risk of early death among these women, without any serious side-effects.

A portable device that detects illicit street drugs on the spot and at very low concentrations, highlighting the dangers they pose, has been developed at Bath.

A new trial of patients with advanced rectal cancer has found that the addition of immunotherapy treatment alongside extended radiotherapy led to better rates of remission.